Literature DB >> 20345418

Modulation and metamodulation of synapses by adenosine.

J A Ribeiro1, A M Sebastião.   

Abstract

The presence of adenosine in all nervous system cells (neurones and glia) together with its intensive release following insults makes adenosine as a sort of 'regulator' of synaptic communication, leading to the homeostatic coordination of brain function. Besides the direct actions of adenosine on the neurosecretory mechanisms, to tune neurotransmitter release, adenosine receptors interact with other receptors as well as with transporters as part of its attempt to fine-tune synaptic transmission. This review will focus on examples of the different ways adenosine can use to modulate or metamodulate synapses, in other words, to trigger or brake the action of some neurotransmitters and neuromodulators, to cross-talk with other G protein-coupled receptors, with ionotropic receptors and with receptor kinases as well as with transporters. Most of these interactions occur through A2A receptors, which in spite of their low density in some brain areas, such as the hippocampus, may function as amplifiers of the signalling of other mediators at synapses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345418     DOI: 10.1111/j.1748-1716.2010.02115.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  23 in total

Review 1.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

Review 2.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

3.  CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS.

Authors:  Maria Rosito; Cristina Deflorio; Cristina Limatola; Flavia Trettel
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 4.  Neuromodulation of neurons and synapses.

Authors:  Farzan Nadim; Dirk Bucher
Journal:  Curr Opin Neurobiol       Date:  2014-06-05       Impact factor: 6.627

5.  Adenosine A1 receptor activates background potassium channels and modulates information processing in olfactory bulb mitral cells.

Authors:  Natalie Rotermund; Svenja Winandy; Timo Fischer; Kristina Schulz; Torsten Fregin; Nadine Alstedt; Melanie Buchta; Janick Bartels; Mattias Carlström; Christian Lohr; Daniela Hirnet
Journal:  J Physiol       Date:  2018-01-24       Impact factor: 5.182

6.  Mixed inhibition of adenosine deaminase activity by 1,3-dinitrobenzene: a model for understanding cell-selective neurotoxicity in chemically-induced energy deprivation syndromes in brain.

Authors:  Yipei Wang; Xin Liu; Brandon Schneider; Elaina A Zverina; Kristen Russ; Sanjeeva J Wijeyesakere; Carol A Fierke; Rudy J Richardson; Martin A Philbert
Journal:  Toxicol Sci       Date:  2011-11-21       Impact factor: 4.849

7.  BDNF-induced presynaptic facilitation of GABAergic transmission in the hippocampus of young adults is dependent of TrkB and adenosine A2A receptors.

Authors:  Mariana Colino-Oliveira; Diogo M Rombo; Raquel B Dias; Joaquim A Ribeiro; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2016-02-20       Impact factor: 3.765

Review 8.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

9.  Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.

Authors:  Sandra Henriques Vaz; Sofia Rapaz Lérias; Sara Parreira; Maria José Diógenes; Ana Maria Sebastião
Journal:  Purinergic Signal       Date:  2015-10-09       Impact factor: 3.765

Review 10.  Short- and long-term (trophic) purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.